GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

Pakistan · Delayed Price · Currency is PKR

358.37

-6.27 (-1.72%)

At close: May 11, 2026

Revenue by Segment

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	65.90B	61.19B	49.66B	41.84B	36.66B
Pharmaceuticals Growth	7.70%	23.21%	18.69%	14.13%	4.48%
Total	65.90B	61.19B	49.66B	41.84B	36.66B
Total Growth	7.70%	23.21%	18.69%	14.13%	4.48%

Revenue by Geography

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pakistan	66.44B	62.22B	51.74B	44.27B	38.12B
Pakistan Growth	6.79%	20.25%	16.88%	16.14%	4.72%
Export	13.46M	15.86M	-	26.47M	28.88M
Export Growth	-15.12%	-	-	-8.36%	70.93%
Unallocated Commissions, Returns and Discounts	98.99M	-417.03M	-1.58B	-	-
Unallocated Sales Tax	-655.48M	-628.93M	-496.75M	-	-
Unallocated	-	-	-	-2.45B	-1.49B
Total	65.90B	61.19B	49.66B	41.84B	36.66B
Total Growth	7.70%	23.21%	18.69%	14.13%	4.48%

Source: S&P Global Market Intelligence.